FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

13867011000001107: Diprosalic scalp application (Doncaster Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
49787501000001116 Diprosalic scalp application (Doncaster Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
78262301000001110 Diprosalic 0.05%/2% scalp application (DE Pharmaceuticals) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Diprosalic scalp application (Doncaster Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Diprosalic scalp application (Doncaster Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Diprosalic scalp application (Doncaster Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Diprosalic scalp application (Doncaster Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Diprosalic scalp application (Doncaster Pharmaceuticals Ltd) Is a Betamethasone+salicylic acid 0.05/3% scalp application false Inferred relationship Existential restriction modifier
Diprosalic scalp application (Doncaster Pharmaceuticals Ltd) Has active ingredient Betamethasone dipropionate false Inferred relationship Existential restriction modifier
Diprosalic scalp application (Doncaster Pharmaceuticals Ltd) Has active ingredient Betamethasone true Inferred relationship Existential restriction modifier
Diprosalic scalp application (Doncaster Pharmaceuticals Ltd) Has active ingredient Salicylic acid true Inferred relationship Existential restriction modifier
Diprosalic scalp application (Doncaster Pharmaceuticals Ltd) Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Diprosalic scalp application (Doncaster Pharmaceuticals Ltd) Has manufactured dose form Basic dose form with liquid state of matter false Inferred relationship Existential restriction modifier
Diprosalic scalp application (Doncaster Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Diprosalic scalp application (Doncaster Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Diprosalic scalp application (Doncaster Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Diprosalic scalp application (Doncaster Pharmaceuticals Ltd) Is a Diprosalic scalp false Inferred relationship Existential restriction modifier
Diprosalic scalp application (Doncaster Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Betamethasone true Inferred relationship Existential restriction modifier
Diprosalic scalp application (Doncaster Pharmaceuticals Ltd) Has specific active ingredient Salicylic acid true Inferred relationship Existential restriction modifier
Diprosalic scalp application (Doncaster Pharmaceuticals Ltd) Has specific active ingredient Betamethasone dipropionate true Inferred relationship Existential restriction modifier
Diprosalic scalp application (Doncaster Pharmaceuticals Ltd) Has dispensed dose form Basic dose form with liquid state of matter true Inferred relationship Existential restriction modifier
Diprosalic scalp application (Doncaster Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Diprosalic scalp application (Doncaster Pharmaceuticals Ltd) Is a Diprosalic true Inferred relationship Existential restriction modifier
Diprosalic scalp application (Doncaster Pharmaceuticals Ltd) Has basis of strength substance Betamethasone true Inferred relationship Existential restriction modifier
Diprosalic scalp application (Doncaster Pharmaceuticals Ltd) Is a Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application false Inferred relationship Existential restriction modifier
Diprosalic scalp application (Doncaster Pharmaceuticals Ltd) Is a Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Diprosalic scalp application (Doncaster Pharmaceuticals Ltd) 100 ml Is pack of False Diprosalic scalp application (Doncaster Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Diprosalic scalp application (Doncaster Pharmaceuticals Ltd) 100 ml Has AMP True Diprosalic scalp application (Doncaster Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start